Meghan R. Steiner
Hematology | Oncology
100 Medical Park Drive, NE
Suite 110
Concord, NC 28025
Suite 110
Concord, NC 28025
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.
Journal: JCO precision oncology
Published: January 31, 2025
High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas.
Journal: Gynecologic oncology reports
Published: March 10, 2022
The evolving role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer.
The evolving role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer.
Journal: Clinical advances in hematology & oncology : H&O
Published: May 14, 2021
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies.
Journal: Gynecologic oncology
Published: February 08, 2019
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
Journal: Circulation. Cardiovascular quality and outcomes
Published: September 20, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026